1-4 of 4
Hans J Salwender
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Salvage Autologous Transplant in Relapsed Multiple Myeloma: Long-Term Follow-Up of the Phase 3 GMMG ReLApsE Trial

Clinical Trials & Observations
Marc-Andrea Baertsch, Jana Schlenzka, Thomas Hielscher, Marc S. Raab, Sandra Sauer, Maximilian Merz, Elias K Mai, Carsten Müller-Tidow, Steffen Luntz, Anna Jauch, Peter Brossart, Martin Goerner, Stefan Klein, Bertram Glass, Peter Reimer, Ullrich Graeven, Roland Fenk, Mathias Haenel, Ivana von Metzler, Hans-Walter Lindemann, Christof Scheid, Igor-Wolfgang W. Blau, Hans J Salwender, Richard Noppeney, Britta Besemer, Katja C. Weisel, Hartmut Goldschmidt
Journal: Blood
Blood blood.2024027342.
https://doi.org/10.1182/blood.2024027342
Published: 2025
Includes: Supplemental data
Journal Articles

Combining Information Regarding Chromosomal Aberrations t(4;14), Del(17p13) and the Copy Number of 1q21 with the International Staging System Classification Allows Stratification of Myeloma Patients Undergoing Autologous Stem Cell Transplantation: Results From the HOVON-65/GMMG HD4 Trial

Kai Neben, MD, Henk M. Lokhorst, MD, Anna Jauch, PhD, Uta Bertsch, MD, Thomas Hielscher, Christiane Heiss, Bronno van der Holt, PhD, Stefan Schmitt, Laila el Jarari, MSc, Hans J. Salwender, MD, Igor W. Blau, Michael Pfreundschuh, MD, Katja Weisel, MD, Ulrich Duehrsen, MD, Walter Lindemann, Christian Teschendorf, Hans Martin, Christof Scheid, Mathias Haenel, MD, Hans Guenter Derigs, Ullrich Graeven, Ingo GH Schmidt-Wolf, Norma Peter, Mohammed Wattad, MD, Steffen P Luntz, Annemiek Broyl, MD, Joerg Schubert, MD, Martin Hoffmann, Martin Goerner, MD, Jochen Tischler, Martin Kaufmann, MD, Marc S Raab, Anthony D. Ho, MD, Helgi van de Velde, MD, PhD, Dirk Hose, MD, Pieter Sonneveld, MD, PhD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2011) 118 (21): 332.
https://doi.org/10.1182/blood.V118.21.332.332
Published: 2011
Journal Articles

DNMT3A mutations Predict for Inferior Outcome in NPM1 -Wildtype and Molecular Unfavorable Cytogenetically-Normal Acute Myeloid Leukemia: A Study of the German-Austrian AMLSG

Verena I. Gaidzik, MD, Richard F. Schlenk, MD, Peter Paschka, MD, Anja Stölzle, Andrea Corbacioglu, PhD, David Nachbaur, MD, Thomas Kindler, MD, Alexander C. Burchardt, MD, Helmut R. Salih, MD, Hans-Günther Mergenthaler, MD, Hans J. Salwender, MD, Daniela Späth, MSc, Lars Bullinger, Juergen Krauter, MD, Arnold Ganser, MD, Hartmut Döhner, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2011) 118 (21): 415.
https://doi.org/10.1182/blood.V118.21.415.415
Published: 2011
Journal Articles

TET2 Mutations In Acute Myeloid Leukemia (AML): Results on 783 Patients Treated within the AML HD98A Study of the AML Study Group (AMLSG)

Verena I. Gaidzik, MD, Richard F. Schlenk, MD, Peter Paschka, MD, Claus-Henning Köhne, MD, Gerhard Held, MD, Marianne Habdank, Juliane Gohlke, Hans-Günther Mergenthaler, MD, Hans J. Salwender, MD, Lars Bullinger, MD, Hartmut Döhner, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2010) 116 (21): 97.
https://doi.org/10.1182/blood.V116.21.97.97
Published: 2010